Skip to main content
48°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ESALY
Recent news which mentions ESALY
< Previous
1
2
3
4
Next >
US Stock Futures Down Ahead Of Fed Speakers, Economic Data
September 28, 2022
Tickers
AGCO
BB
BIIB
CTAS
Tags
News
Pre/Market Outlook
Earnings
From
Benzinga
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
September 28, 2022
Tickers
BIIB
ESALY
Tags
JP:NIK
ESALY
BIIB
From
MarketWatch
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
FDA
lecanemab
Benzinga
From
Benzinga
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
September 12, 2022
Tickers
ESALF
ESALY
MRK
Tags
Market News
MRK
Benzinga
From
Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
August 25, 2022
Tickers
ESALF
ESALY
LLY
RHHBF
Tags
RHHBY
General
Briefs
From
Benzinga
Here's What Could Make This Beaten-Down Stock a Buy
August 19, 2022
Tickers
BIIB
ESALY
Tags
Market News
ESALY
BIIB
From
Motley Fool
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
JAZZ
MCRB
News
From
Benzinga
Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal
August 03, 2022
Tickers
ESALF
ESALY
MRK
Tags
Biotech
Large Cap
Health Care
From
Benzinga
Merck's Oncology Business Will Help It Crush the Bear Market
July 07, 2022
Tickers
AZN
ESALY
MRK
SGEN
Tags
Market News
SGEN
MRK
From
Motley Fool
Is This Biotech Stock a Bad News Buy?
July 06, 2022
Tickers
BIIB
ESALY
Tags
Market News
ESALY
BIIB
From
Motley Fool
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
July 06, 2022
Tickers
AMTI
BIIB
ESALF
ESALY
Tags
PHGE
Penny Stocks
Benzinga
From
Benzinga
2 Safe Stocks to Buy in a Bear Market
May 21, 2022
Tickers
AZN
ESALY
ISRG
MDT
Tags
MRK
Market News
MDT
From
Motley Fool
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Tickers
AGEN
ARWR
ATNX
AVGR
Tags
Earnings
ATNX
XENE
From
Benzinga
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
May 10, 2022
Tickers
BIIB
ESALF
ESALY
Tags
FDA
Benzinga
Market News
From
Benzinga
1 Reason to Buy Biogen Now, and 1 Reason to Wait
May 05, 2022
Tickers
BIIB
ESALY
SAGE
Tags
Recent Press Releases
BIIB
SAGE
From
Motley Fool
Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’
April 29, 2022
Tickers
ESALY
LLY
PFE
SPX
Tags
DK:NOVO/B
ESALY
SPX
From
MarketWatch
Is This Biotech Stock Worth the Trouble?
April 23, 2022
Tickers
BIIB
ESALY
LLY
SAGE
Tags
LLY
Market News
SAGE
From
Motley Fool
What This Regulatory Approval Could Mean for Merck
April 05, 2022
Tickers
ESALY
MRK
PFE
Tags
Market News
MRK
ESALY
From
Motley Fool
The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study
April 01, 2022
Tickers
ABIO
ESALY
IBB
IMMP
Tags
FDA
Benzinga
Penny Stocks
From
Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Benzinga
Phase 2 Trial
Market News
From
Benzinga
FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer
March 22, 2022
Tickers
ESALF
ESALY
MRK
Tags
FDA
Benzinga
MRK
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
Briefs
News
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
IDYA
SXTC
Earnings
From
Benzinga
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
March 04, 2022
Tickers
BIIB
CEMI
ESALY
EYEN
Tags
Penny Stocks
FDA
Benzinga
From
Benzinga
Merck-Eisai's Keytruda/Lenvima Combo Scores Japanese Approval For Kidney Cancer Setting
February 25, 2022
Tickers
ESALF
ESALY
MRK
Tags
Health Care
General
ESALY
From
Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
Tickers
ALKS
AMGN
ARGX
BGNE
Tags
AMGN
NVAX
BGNE
From
Benzinga
Merck Snags Yet Another Indication for This Drug Combo
January 14, 2022
Tickers
ESALY
MRK
Tags
Market News
MRK
ESALY
From
Motley Fool
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Market News
LLY
Trading Ideas
From
Benzinga
Biogen Outlines Aduhelm's Confirmatory Trial Plans, Data Expected In 2026
December 16, 2021
Tickers
BIIB
ESALF
ESALY
Tags
Benzinga
FDA
Market News
From
Benzinga
Europe Approves Merck-Eisai's Keytruda/Lenvima Combo Therapy For Endometrial Carcinoma
November 29, 2021
Tickers
ESALF
ESALY
MRK
Tags
Market News
ESALF
MRK
From
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.